REGEN-COV (casirivimab/imdevimab)

casirivimab and imdevimab · Regeneron

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for REGEN-COV (casirivimab/imdevimab), covering 2021-02-26 to 2021-02-26. Get the full timeline:

Most recent: EMA issues advice on use of REGN-COV2 antibody combination (casirivimab / imdevimab)